Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 12.97% is 16% above its 5-year average of 11.16%, near the high end of its 5-year range (8.70%–14.02%).
As of the fiscal period ended Wednesday, December 31, 2025. 18.88% above its 12-month average of 10.91%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
12.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
11.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
11.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
12.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
13.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.88%
CURRENT VS 3Y AVG
+14.27%
CURRENT VS 5Y AVG
+16.24%
CURRENT VS 10Y AVG
+7.70%
CURRENT VS 15Y AVG
-3.22%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+52.05%
vs the sector median at left
AbbVie Inc.
Market Cap
$458.11B
Return on Invested Capital (ROIC)
12.97%
TTM Avg
10.91%
3Y Avg
11.35%
5Y Avg
11.16%
Market Cap
$382.09B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
10.28%
3Y Avg
12.20%
5Y Avg
12.63%
Market Cap
$323.72B
Return on Invested Capital (ROIC)
18.27%
TTM Avg
18.62%
3Y Avg
14.12%
5Y Avg
12.73%
Market Cap
$634.06B
Return on Invested Capital (ROIC)
13.71%
TTM Avg
13.73%
3Y Avg
14.10%
5Y Avg
13.87%
Market Cap
$262.31B
Return on Invested Capital (ROIC)
13.03%
TTM Avg
11.66%
3Y Avg
9.40%
5Y Avg
7.60%
Market Cap
$216.72B
Return on Invested Capital (ROIC)
29.53%
TTM Avg
34.26%
3Y Avg
43.03%
5Y Avg
88.96%
Market Cap
$211.18B
Return on Invested Capital (ROIC)
7.58%
TTM Avg
7.80%
3Y Avg
8.16%
5Y Avg
9.10%
Market Cap
$202.95B
Return on Invested Capital (ROIC)
13.16%
TTM Avg
11.04%
3Y Avg
11.80%
5Y Avg
12.80%
Market Cap
$179.58B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
9.16%
3Y Avg
9.70%
5Y Avg
9.86%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $458.11B | 12.97% | 10.91% | 11.35% | 11.16% |
| UnitedHealth Group Incorporated (UNH)vs › | $382.09B | 8.23% | 10.28% | 12.20% | 12.63% |
| Merck & Co., Inc. (MRK)vs › | $323.72B | 18.27% | 18.62% | 14.12% | 12.73% |
| Johnson & Johnson (JNJ)vs › | $634.06B | 13.71% | 13.73% | 14.10% | 13.87% |
| AstraZeneca PLC (AZN)vs › | $262.31B | 13.03% | 11.66% | 9.40% | 7.60% |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 29.53% | 34.26% | 43.03% | 88.96% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | 7.58% | 7.80% | 8.16% | 9.10% |
| Amgen Inc. (AMGN)vs › | $202.95B | 13.16% | 11.04% | 11.80% | 12.80% |
| Abbott Laboratories (ABT)vs › | $179.58B | 8.43% | 9.16% | 9.70% | 9.86% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 21.53% | 11.95% | 11.58% | 9.92% |
ROIC
13.0%
ROE
13.2%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 12.97% |
| 2024-12-31 | 8.85% |
| 2023-12-31 | 9.56% |
| 2022-12-31 | 14.02% |
| 2021-12-31 | 12.85% |
| 2020-12-31 | 8.70% |
| 2019-12-31 | 15.71% |
| 2018-12-31 | 13.46% |
| 2017-12-31 | 10.83% |
| 2016-12-31 | 12.43% |
| 2015-12-31 | 13.09% |
| 2014-12-31 | 12.42% |
| 2013-12-31 | 19.27% |
| 2012-12-31 | 25.19% |
| 2011-12-31 | 24.84% |
| 2010-12-31 | 23.46% |
| 2009-12-31 | 0.00% |
